Search

everythinglearnresearchcommunity

for

Search:↓

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

mTOR inhibitors may help treat lung fibrosis.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Key genes IRF2BP2 and EGFR are linked to Hetian sheep's double-coat fleece.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

The compound 4c showed strong potential as an anticancer agent.

Mutations in the spike protein affect drug binding and effectiveness.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

ceRNA networks offer potential treatments for skin aging and wound healing.

Cepharanthine shows promise as a natural anticancer treatment.

miRNA-24 affects goat coat color by controlling proteins involved in pigment production.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Decorin helps hair cells grow and move, and keeps hair growth phase going in mice.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Understanding hair growth involves complex interactions between molecules and could help treat hair disorders.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

AP-1 controls tumor cell type by affecting key signaling pathways.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

PSAT1 is key for hair growth and stem cell function in cashmere goats.